HIGHLIGHTS
- who: Mario Nuvolone et al. from the Department of Molecular Medicine, University of Pavia, Pavia, Italy have published the article: Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy, in the Journal: (JOURNAL)
- what: Novel, effective, oral drugs have been recently introduced for ATTR cardiac amyloidosis, which are the focus of this review. This study demonstrated that a supra-therapeutic single 400 mg oral 8 of 22 dose of tafamidis does not prolong the corrected QT interval and is well tolerated in healthy volunteers .
- how: The study was conducted on 130 patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.